Cancer Genomics and Diagnostics
Cancer Genomics and Diagnostics is a research topic within Cancer Research. Science Explorer counts 60k research works in it since 1950. 18.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the genomic landscape of cancer, mutational signatures, intratumor heterogeneity, liquid biopsies, somatic mutations, tumor evolution, cell-free DNA, genomic instability, targeted therapy, and clonal evolution in various cancer types.
- Cancer Genomics
- Mutational Signatures
- Intratumor Heterogeneity
- Liquid Biopsies
- Somatic Mutations
- Tumor Evolution
- Cell-Free DNA
- Genomic Instability
- Targeted Therapy
- Clonal Evolution
- Research works
- 60k fractional, since 1950
- In the world top 10%
- 11k per year above
- Top-10% rate
- 18.3% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +53% the tick is no change
Which countries lead Cancer Genomics and Diagnostics research?
By volume, the United States and China publish the most (5.4k and 2.3k works in 2022–2025).
By volume, 2022–2025
- 1 United States 5.4k works
- 2 China 2.3k works
- 3 United Kingdom 692 works
- 4 Germany 664 works
- 5 Italy 631 works
- 6 Japan 622 works
- 7 India 521 works
- 8 France 458 works
- 9 Canada 421 works
- 10 Spain 405 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cancer Genomics and Diagnostics research?
By volume in 2022–2025, The University of Texas MD Anderson Cancer Center publishes the most Cancer Genomics and Diagnostics research, followed by Memorial Sloan Kettering Cancer Center and Dana-Farber Cancer Institute.
By volume, 2022–2025
- 1 The University of Texas MD Anderson Cancer CenterUnited States 202 works
- 2 Memorial Sloan Kettering Cancer CenterUnited States 144 works
- 3 Dana-Farber Cancer InstituteUnited States 82 works
- 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 76 works
- 5 Harvard UniversityUnited States 75 works
- 6 University of North Carolina at Chapel HillUnited States 72 works
- 7 Stanford UniversityUnited States 67 works
- 8 Johns Hopkins UniversityUnited States 66 works
- 9 Sun Yat-sen UniversityChina 59 works
- 10 Washington University in St. LouisUnited States 58 works
Who are the leading researchers in Cancer Genomics and Diagnostics?
The most-cited researchers publishing on Cancer Genomics and Diagnostics include Robert Tibshirani, Stacey Gabriel and Bert Vogelstein.
- 1 Robert Tibshirani United States 13k citations
- 2 Stacey Gabriel United States 7.8k citations
- 3 Bert Vogelstein United States 7.1k citations
- 4 Todd R. Golub United States 6.8k citations
- 5 Benjamin L. Ebert United States 6.7k citations
- 6 Gad Getz United States 6.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cancer Genomics and Diagnostics research done?
The largest centres of Cancer Genomics and Diagnostics research in 2022–2025 are New York (United States), Beijing (China), Houston (United States) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Cambridge, San Carlos and Redwood City.
Largest cities, 2022–2025
Where it is the local speciality
- Cambridge24.3 works124×
- San CarlosUS · 22.1 works96×
- Redwood CityUS · 44.7 works44×
Location quotient: how much more of its research is in Cancer Genomics and Diagnostics than the world average.
Where is the best place to study Cancer Genomics and Diagnostics?
Among universities, judged by research, Oncode Institute, Institute of Cancer Research and Shanghai Medical College of Fudan University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Oncode InstituteNetherlands | 74.8 | 36.0% | 32.2× | 14 | +206.5% |
| 2 | Institute of Cancer ResearchUnited Kingdom | 58.4 | 23.5% | 38.8× | 18 | +75.0% |
| 3 | Shanghai Medical College of Fudan UniversityChina | 58.3 | 30.7% | 9.7× | 11 | +99.7% |
| 4 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 56.7 | 18.7% | 5.4× | 76 | +249.9% |
| 5 | Icahn School of Medicine at Mount SinaiUnited States | 55.8 | 20.0% | 5.8× | 41 | +278.2% |
| 6 | Weill Cornell MedicineUnited States | 53.6 | 18.7% | 11.7× | 22 | — |
| 7 | Heidelberg UniversityGermany | 52.6 | 26.9% | 4.8× | 37 | +99.9% |
| 8 | Chinese University of Hong KongHong Kong | 51.9 | 35.9% | 2.0× | 20 | +115.9% |
| 9 | Harbin Medical UniversityChina | 51.7 | 18.2% | 8.0× | 24 | +148.0% |
| 10 | Medical University of GrazAustria | 51.1 | 23.7% | 7.4× | 13 | +103.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cancer Genomics and Diagnostics research growing?
Output in 2018–2022 was 53% higher than in 2013–2017, peaking in 2023. The fastest-growing topics are Cancer Genomics and Diagnostics.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.